英语论文网

UK.
Poor capability and smaller investment of drug research. Drug research refers to the whole process from the drug laboratory to put the drug on the market, which is a systematic process combining all disciplines and high-tech techniques.
With the development of the society, demographic changes, changes in diseases, and changes in the ecological environment, life cycle of drugs are getting shorter, and the frequency of upgrading is much faster.
Enterprise management level is low. Many pharmaceutical companies are experiencing a serious shortage of management talents.

3) Opportunities
According to statistics, the growth of aging-associated drug market will be 2%-5% higher than the whole industry rate;
High prevalence rate of aging people results in huge demands of aging-associated drugs. Prevalence rate of aging people if more than that of young people, aging people is the high-risk population of disease. Compared with other age groups, drug counts of aging people are more than other age groups.
E-commerce providers and online sales will bring new opportunities. Consumers search drugs and pharmacies online through searching engines, the drug-related information and legitimacy can be obtained in a very short period of time. E-commerce will change the consumption models and also bring new opportunities for pharmaceutical companies.
Medication adherence can be improved. Aging-associated drug industry can promote the medication adherence. A lot of products, devices might be designed to improve the organization of medications. For example, calendars reminding aging people to come to see doctors; electronic pill dispensers help them to organize drugs they take every day; compartmentalized containers and other products and designs are all congruent with a medications schedule.
Health care delivery can be improved. Health care delivery is a new opportunity for pharmaceutical market. Engineer applications and technology applications etc., could improve the efficiency and convenience to deliver health care to people who are frail or have limited mobility. In order to make health care more professional and easy to deliver, facilitate access to health care information and services would be quite popular in the pharmaceutical market.

4) Threats
The number of people aged over 85 years old is projected to more than double, reaching 3.6 millions in the UK. However, aging-associated drugs and supplies in the UK are not going well. The development and production of aging-associated drugs and equipment are far more enough.
More prescription drugs are transferred to OTC (Over The Counter) drugs. The therapeutic area of OTC gets wider. However, as more and more OTC drugs appear, competitions among OTC drugs become increasingly fierce, in today’s pharmaceutical market, the battle reaches the white hot point.
Phenomena of unfair competitions among pharmaceutical companies are increasing prominent. This is an evitable result of repetitive production, excessive imitation and homogeneous competition.